Precap from SPAC Track

The Precap newsletter: SPAC Track’s morning recap of the action in the SPAC world for premium subscribers. (Feb 24, 2022)

The Stats:

Pre-Market Movers:

DWAC -9.4%, CFVI -7%, GGPI -5.5%, SNII -5.2%

Yesterday’s Movers and Volume Leaders:

SPAC Track @SPACtrack

#SPACVolume Leaders (2/23/22) $DWAC 4.8M $CND 3.4M $GGPI 2.8M $CFVI 2.5M $IPOF 2.4M $SNII 2.3M (-16%) $FMAC 1.8M $FPAC 1.5M $ESSC 1.2M $VTIQ 1.1M

---

The Deals:

No new deals today.

---

News:

Life Insurance Epigenetics Startup Foxo Plans to Go Public Via SPAC [Delwinds Insurance Acquisition Corp. (DWIN)]

---

Merger Votes/ Completions/ Extensions:

• ARYA Sciences Acquisition Corp IV (ARYD) and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market Conditions

• Goldenbridge Acquisition Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination tp 6/4/22

---

New SPACs (S-1s):

No new S-1s

Registration Withdrawals:

• GSR II Meteora Acquisition Corp

• Jaws Wildcat Acquisition

• Leo Holdings IV Corp

---

If you find this newsletter useful, feel free to share it with a friend (the free version of the newsletter) and suggest they subscribe:

---

De-SPAC S-1s (including PIPE resale registrations*):

S-1 Filings:

• Codere Online (CDRO)

*When applicable

---

S-4 Activity:

No activity

---

Upcoming Dates:

Upcoming Announced Shareholder Meetings, Unit Splits, Warrant Redemptions

See the full calendar here.

---

Notes:

All the Pro data points on the Pro Screener along with which table “view” and export eligibility can be found here: spactrack.io/screener-instructions

---

Thanks for reading,

SPAC Track

spactrack.io

DISCLAIMER: The information provided in this newsletter is for your convenience only and is not intended to be treated as financial, investment, tax, or other advice. SPAC Track and its parent, CommonFi, do not make any guarantees, representations, or warranties as to, and shall have no liability for, the timeliness, truthfulness, sequence, quality, completeness, or accuracy of any of the information or data provided in this newsletter or on the SPAC Track website.